PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature
about
Essential role of the coxsackie- and adenovirus receptor (CAR) in development of the lymphatic system in miceThree-dimensional analysis of vascular development in the mouse embryoALK1 signaling regulates early postnatal lymphatic vessel developmentEph/ephrin molecules--a hub for signaling and endocytosisNon-SH2/PDZ reverse signaling by ephrinsFOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in miceHeterogeneity in the lymphatic vascular system and its originDevelopment of the mammalian lymphatic vasculatureBroad targeting of angiogenesis for cancer prevention and therapyEPHB4 kinase-inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis.FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature.Lymph flow regulates collecting lymphatic vessel maturation in vivo.Diphtheria toxin-mediated ablation of lymphatic endothelial cells results in progressive lymphedema.VEGF signaling inside vascular endothelial cells and beyond.Lymphatic regulator PROX1 determines Schlemm's canal integrity and identityLymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activitySpatial regulation of VEGF receptor endocytosis in angiogenesisClaudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel developmentSmooth muscle-endothelial cell communication activates Reelin signaling and regulates lymphatic vessel formationEph receptor signalling casts a wide net on cell behaviourLymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding.EphB-ephrin-B2 interactions are required for thymus migration during organogenesis.Discontinuous LYVE-1 expression in corneal limbal lymphatics: dual function as microvalves and immunological hot spots.Sinusoidal ephrin receptor EPHB4 controls hematopoietic progenitor cell mobilization from bone marrow.Ephrin B1 regulates bone marrow stromal cell differentiation and bone formation by influencing TAZ transactivation via complex formation with NHERF1.Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from gene-targeting of the PI3K regulatory isoforms p85alpha, p55alpha, and p50alpha.Tumors induce coordinate growth of artery, vein, and lymphatic vessel triads.Murine Notch1 is required for lymphatic vascular morphogenesis during developmentEphA4 and EfnB2a maintain rhombomere coherence by independently regulating intercalation of progenitor cells in the zebrafish neural keel.RASA1 functions in EPHB4 signaling pathway to suppress endothelial mTORC1 activity.Integrin-α5β1 is not required for mural cell functions during development of blood vessels but is required for lymphatic-blood vessel separation and lymphovenous valve formation.Specification of arterial, venous, and lymphatic endothelial cells during embryonic development.An exquisite cross-control mechanism among endothelial cell fate regulators directs the plasticity and heterogeneity of lymphatic endothelial cellsThe lymphatic system in health and disease.Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis.Targeting lymphatic vessel functions through tyrosine kinases.Lymphatics in lung disease.Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development.
P2860
Q21134565-14830239-3998-4048-A5B6-614B703D7225Q21144270-5A67C4F5-9456-44B4-B484-3D64E3B94AE0Q24316206-8A8B5059-8334-40E6-BA48-E34920E573FDQ24611588-D28738AF-5DB8-4720-8283-C41183108A7FQ24629619-5E869A33-A6C1-4781-B6B5-581622A995A9Q24641842-DD75E361-FE0C-48E6-BCCF-9D6530319E6DQ24652041-F02B1971-F469-43F9-BCA0-4531274A5F75Q26746060-855BF6BC-1486-4AC3-99F6-F5FD69E1E9CAQ26852649-D9F75E3E-FF13-4E70-BF95-0F12A7DC8F0BQ27002903-77ADBAA9-C61B-4F27-8779-68123E976293Q27329626-B87C07FE-35AC-4B34-A4B3-606E241AEE01Q27332286-A40EA2AD-B74E-4653-85A0-777FF53C3D52Q27332557-4E156DB5-997E-4BF5-BE2D-EE7FD020EA94Q27334274-B99125EC-0E17-4552-B265-9BB5739CA9EEQ27687815-858732B7-01DA-40BC-8D0B-90B9B45DAE6DQ28244698-101AA76A-78F3-4AAD-A441-9BCC498501B1Q28584887-87B354F1-2DAE-4EF0-8310-7DB0BDF5B81FQ28585752-3AA84D6A-8E05-4CE2-A4E4-5FBE315523D8Q28586394-97CFE270-8534-404C-AA35-51F76B6B4C52Q28590754-7CBF9035-F469-423F-AB0A-948BE5FEAF49Q29619988-08CE1CF3-D64B-4FCE-A998-BA592C64C5B3Q30275974-C00EC3D5-A073-4B95-8368-A80F83B78B73Q30493939-07B0119E-D4AB-4907-B025-33A4B71584F0Q30496070-D9E84ADC-3680-432A-8397-C47A3543A331Q30506032-677B2FB1-4A75-4357-A416-A47A9926074DQ30830186-9C970A74-3EA4-44AB-8146-5B6F432EFE02Q33613966-48253258-DCFA-4146-907A-2EF0CC41143FQ33680436-E0FCE7B2-E7F1-4294-88BF-25E3BBE2ACBFQ33712485-0CDFF488-366C-4933-BB7B-FCD565E264F6Q33774250-215FA5AA-F474-46FE-BB3C-F7161DB7E01DQ33819483-666FC6FD-66CC-4258-980F-A662EC3EDBB8Q33872553-5130B4CC-9AC3-472D-8034-B48DCF2E5596Q33963025-EC929D4A-858D-4C9A-ABA3-FED4B4D8850AQ33973350-2C2B8A93-AC87-434A-AEE1-62DBEF733BE9Q33997193-93FEE171-AEBA-4495-AD81-1FD29B115B23Q34015299-9C4867B3-C4ED-4867-B011-60F7FE4754DCQ34031959-1A7C3A92-6407-47EB-8B91-440394D5F974Q34078275-9E4024CC-71DD-47DE-AE5E-EBBF073A42AEQ34160672-7D4EA173-51D1-49E9-9115-E018B0BF321FQ34162552-F1D5D61B-8676-404E-ABCB-037425D518C9
P2860
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature
description
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2005
@ast
im Februar 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/02/01)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/02/01)
@nl
наукова стаття, опублікована в лютому 2005
@uk
مقالة علمية (نشرت في فبراير 2005)
@ar
name
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature
@ast
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature
@en
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature
@nl
type
label
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature
@ast
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature
@en
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature
@nl
prefLabel
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature
@ast
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature
@en
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature
@nl
P2093
P2860
P3181
P356
P1433
P1476
PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature
@en
P2093
Andrew Ziemiecki
George A. Wilkinson
John Bailey
Rüdiger Klein
Taija Mäkinen
P2860
P304
P3181
P356
10.1101/GAD.330105
P577
2005-02-01T00:00:00Z